Edition:
India

Profile: SanBio Co Ltd (4592.T)

4592.T on Tokyo Stock Exchange

3,405JPY
11:13am IST
Change (% chg)

¥-45 (-1.30%)
Prev Close
¥3,450
Open
¥3,505
Day's High
¥3,540
Day's Low
¥3,395
Volume
393,000
Avg. Vol
1,259,026
52-wk High
¥12,730
52-wk Low
¥2,401

SanBio Company Limited is a Japan-based company primarily engaged in the research and development of regenerative cells drugs. The Company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

Company Address

SanBio Co Ltd

28F, St. Luke's Tower, 8-1, Akas
CHUO-KU   TKY   104-0044
P: +813.62643481

Company Web Links